Acetaminophen and Stevens-Johnson Syndrome (SJS) in California: Can You Hold Makers Liable?
TL;DR: The FDA has warned that rare but serious skin reactions, including SJS/TEN, can occur with acetaminophen (FDA safety communication). In California, a lawsuit may be possible, but these cases are usually expert- and records-intensive: you must prove medical causation and a viable legal theory (often failure to warn). If you want an individualized evaluation, contact us.
SJS/TEN are life-threatening reactions that can involve widespread blistering/peeling, mucous membrane injury, hospitalization, and long-term complications (including ocular injury). Legally, cases often come down to whether acetaminophen was a substantial factor versus other triggers (other medications, infections), and whether the product’s warnings and risk communication were adequate given what was known or knowable at the time.
SJS/TEN and acetaminophen: why these cases can be complex
The FDA has advised consumers to stop acetaminophen and seek medical attention if a skin rash or related symptoms occur (FDA). That warning matters in litigation, but it does not automatically establish liability. The details of the product used, the labeling, timing, and medical differential diagnosis typically determine whether a claim is viable.
Who might be legally responsible in California?
Depending on the product and supply chain, potential defendants may include the manufacturer (brand or generic), entities involved in labeling/marketing/distribution, and sometimes sellers/retailers in the distribution chain. California can apply strict products liability broadly within the chain of distribution in appropriate cases (see Vandermark v. Ford Motor Co.).
California product-liability basics (strict liability and negligence)
California recognizes strict product liability theories commonly framed as manufacturing defect, design defect, and warning/instruction defect (see Greenman v. Yuba Power Products, Inc.; design-defect frameworks discussed in Barker v. Lull Engineering Co.). Plaintiffs also often plead negligence theories (for example, negligent risk communication), but viability is highly fact-dependent.
Failure-to-warn claims: what the case often turns on
In medication injury cases, warning adequacy is often central. Common factual issues include:
- Clarity and prominence: Did consumer packaging (OTC) or professional labeling (prescription) communicate the risk of severe skin reactions in a way likely to be noticed and understood?
- Actionable instructions: Did warnings tell users what symptoms require stopping the drug and seeking urgent care?
- Timeliness: Were warnings updated as safety information developed?
For prescription products, California generally evaluates warnings through a learned-intermediary framework in many circumstances (see Carlin v. Superior Court). For OTC products, consumer-facing labeling often becomes especially important because consumers may self-select and self-dose.
Design-defect theories in drug cases: possible, but constrained and fact-dependent
Drug design-defect claims can be legally and practically difficult. In California, strict-liability design claims for prescription drugs are limited in many contexts (see Brown v. Superior Court). Depending on the product and circumstances, other theories (including negligence-based theories) may still be explored, but outcomes often turn on regulatory posture, available evidence, and how the claim is framed.
Causation: proving acetaminophen was a substantial factor
Causation is frequently the battleground. A viable case often depends on detailed medical records and expert review addressing:
- Timeline: Symptom onset relative to acetaminophen exposure and other medications.
- Differential diagnosis: Evaluation of other plausible triggers (other drugs, infections, etc.).
- Clinical confirmation: Documentation consistent with SJS/TEN (and any biopsy/pathology).
- Product identification: Exact product(s) used (including OTC combination products that contain acetaminophen) and, if available, lot/packaging details.
Tip: protect product identification early
If you still have the bottle/box, photograph every panel (front, back, Drug Facts, NDC/UPC, lot number) and keep receipts if available. Product ID problems can derail otherwise strong medical-causation evidence.
Checklist: what to gather for a California case review
- Packaging and proof of purchase: Bottles/boxes, photos of labels, receipts, pharmacy records.
- Complete medical records: ER, inpatient, dermatology, ophthalmology, pathology/biopsy, discharge summaries.
- Medication timeline: All prescriptions, OTC products (including cold/flu combinations), and supplements taken in the weeks before onset.
- Photos and follow-up care: Progression photos and records of ongoing complications.
Common defenses you should expect (including generic-drug preemption issues)
Defendants often dispute causation, argue warnings were adequate, or assert misuse (for example, exceeding labeled dosing or taking multiple acetaminophen-containing products). In some cases, especially involving generic drugs, companies may argue federal law limits certain state-law claims (see PLIVA, Inc. v. Mensing; Mutual Pharmaceutical Co. v. Bartlett). The applicability of these defenses depends on the specific product (OTC vs. prescription; brand vs. generic) and the theory asserted.
What damages may be available in California?
If liability is established, damages may include past and future medical costs, lost income/earning capacity, and non-economic damages such as pain and suffering. Punitive damages may be pursued in appropriate cases with sufficient proof under California standards, but they are not automatic.
FAQ
Is acetaminophen linked to SJS/TEN?
The FDA has warned that rare but serious skin reactions, including SJS/TEN, have been associated with acetaminophen and advises stopping the drug and seeking medical attention if symptoms occur (FDA safety communication).
Does the FDA warning mean the manufacturer is automatically liable?
No. Liability typically requires proof of causation and a viable legal theory (often warning-related), plus overcoming defenses specific to the product and circumstances.
Who can be sued in California?
Potential defendants can include manufacturers and, in some situations, others in the distribution chain, depending on the facts and product history (see Vandermark).
How long do I have to file in California?
Deadlines can be fact-dependent, but many personal injury claims are subject to a two-year limitations period (see California Code of Civil Procedure section 335.1). Discovery rules, tolling, and claim type can affect the analysis, so getting case-specific advice quickly matters.
Next step: talk to a California product-liability attorney
If you or a family member developed SJS/TEN after acetaminophen use, a records-driven review can help determine whether there is a viable California claim and what defendants and defenses may be involved. Contact us here to request an evaluation.
California-specific disclaimer: This article is for general informational purposes only and is not legal advice. It does not create an attorney-client relationship. Product-liability, preemption, causation, and limitations issues are highly fact-specific and can change with new decisions or regulatory actions. For advice about your situation, consult a qualified California attorney promptly.